blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3890486

EP3890486 - C3-C5 N-ALKYL-GAMMA-BUTYROLACTAM-CONTAINING ANTIMICROBIAL COMPOSITIONS AND USES THEREOF [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  13.09.2024
Database last updated on 28.09.2024
FormerRequest for examination was made
Status updated on  10.09.2021
FormerThe international publication has been made
Status updated on  13.06.2020
Most recent event   Tooltip18.09.2024New entry: Despatch of examination report + time limit 
Applicant(s)For all designated states
Virox Technologies Inc.
2770 Coventry Road
Oakville, Ontario L6H 6R1 / CA
[2021/41]
Inventor(s)01 / ALDERSON, Faraz A.
2770 Coventry Road
Oakville, Ontario L6H 6R1 / CA
 [2021/41]
Representative(s)ABG Intellectual Property Law, S.L.
Avenida de Burgos, 16D
Edificio Euromor
28036 Madrid / ES
[2021/41]
Application number, filing date19892728.704.12.2019
[2021/41]
WO2019CA51740
Priority number, dateUS201862774964P04.12.2018         Original published format: US 201862774964 P
[2021/41]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020113331
Date:11.06.2020
Language:EN
[2020/24]
Type: A1 Application with search report 
No.:EP3890486
Date:13.10.2021
Language:EN
The application published by WIPO in one of the EPO official languages on 11.06.2020 takes the place of the publication of the European patent application.
[2021/41]
Search report(s)International search report - published on:CA11.06.2020
(Supplementary) European search report - dispatched on:EP06.07.2022
ClassificationIPC:A01N43/36, A01P1/00, A61L2/16
[2021/41]
CPC:
A01P1/00 (EP); A01N43/36 (EP,US); A01N25/30 (US);
A61L2/16 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/41]
TitleGerman:C3-C5 N-ALKYL-GAMMA-BUTYROLACTAM-ENTHALTENDE ANTIMIKROBIELLE ZUSAMMENSETZUNGEN UND VERWENDUNGEN DAVON[2021/41]
English:C3-C5 N-ALKYL-GAMMA-BUTYROLACTAM-CONTAINING ANTIMICROBIAL COMPOSITIONS AND USES THEREOF[2021/41]
French:COMPOSITIONS ANTIMICROBIENNES CONTENANT N-ALKYL-GAMMA-BUTYROLACTAME EN C3-C5 ET LEURS UTILISATIONS[2021/41]
Entry into regional phase23.06.2021National basic fee paid 
23.06.2021Search fee paid 
23.06.2021Designation fee(s) paid 
23.06.2021Examination fee paid 
Examination procedure02.10.2020Request for preliminary examination filed
International Preliminary Examining Authority: CA
23.06.2021Examination requested  [2021/41]
17.01.2023Amendment by applicant (claims and/or description)
17.09.2024Despatch of a communication from the examining division (Time limit: M04)
Fees paidRenewal fee
18.11.2021Renewal fee patent year 03
10.11.2022Renewal fee patent year 04
04.12.2023Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]GB1169113  (BASF AG [DE]);
 [I]US5035859  (GU BEN [US], et al);
 [I]WO2008052031  (ALCON MFG LTD [US], et al);
 [X]WO2013107822  (TAMINCO [BE]);
International search[XY]GB1525120  (NELSON RES & DEV) [X] 5, 11, 12, 14-16, 18 and 20-22 [Y] 5-16 and 18-22;
 [XY]US4132781  (STOUGHTON RICHARD B) [X] 5, 11, 12, 14-16, 18 and 20-22 [Y] 5-16 and 18-22;
 [A]US4305749  (MILDENBERGER HILMAR, et al) [A] 17-22;
 [X]CA2007239  (BAYER AG [DE]) [X] 17-22;
 [X]WO03094920  (TIBOTEC PHARM LTD [IE], et al) [X] 1, 2, 4-18, 20 and 21;
 [A]US2004192933  (MANZER LEO ERNEST [US], et al) [A] 17-22;
 [X]WO2006005551  (BAYER CROPSCIENCE AG [DE], et al) [X] 17-22;
 [X]JP2007031299  (TAISHO TECHNOS CO LTD) [X] 18-22;
 [A]US2008095863  (KABRA BHAGWATI P [US]) [A] 1-22;
 [X]  - DHAVAN, A.A., "Antibacterial and Antifungal Activities of2,3-Pyrrolidinedione Derivatives Against Oral Pathogens", Bioorganic and Medicinal Chemistry Letters, (20160204), vol. 26, no. 5, doi:10.1016/j.bmcl.2016.01.082, pages 1376 - 1380, XP029418008 [X] 17

DOI:   http://dx.doi.org/10.1016/j.bmcl.2016.01.082
 [X]  - ZENG, X.H., "Antifungal activities of (E)-4-Benzylidene-5-oxopyrrolidine- 2- carboxamides and 6-Oxo-1,2,3, 6-tetrahydropyridin-2-carboxamides Synthezed via Ugi Reaction from Baylis-Hillman Bromides", 2nd International Conference on Agricultural and Biological Sciences (ABS 2016): IOP Conference Series: Earth and Environmental Science, (20160000), vol. 41, pages 1 - 5, XP055717227 [X] 17 and 19

DOI:   http://dx.doi.org/10.1088/1755-1315/41/1/012017
 [A]  - HOSSEINZADEHA, Z. et al., "An Overview on Chemistry and Biological Importance of Pyrrolidinone", Current Organic Synthesis, (20180301), vol. 15, no. 2, pages 166 - 178, XP055717228 [A] 1-22 * ; in particular: Section 4 and Figure 36 (page 172-174) *

DOI:   http://dx.doi.org/10.2174/1570179414666170908165445
by applicantGB1525120
 US4132781
 US2015057375
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.